Ana Florea

2.1k total citations · 1 hit paper
42 papers, 1.1k citations indexed

About

Ana Florea is a scholar working on Infectious Diseases, Epidemiology and Health. According to data from OpenAlex, Ana Florea has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Epidemiology and 8 papers in Health. Recurrent topics in Ana Florea's work include SARS-CoV-2 and COVID-19 Research (13 papers), Vaccine Coverage and Hesitancy (8 papers) and COVID-19 Clinical Research Studies (7 papers). Ana Florea is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), Vaccine Coverage and Hesitancy (8 papers) and COVID-19 Clinical Research Studies (7 papers). Ana Florea collaborates with scholars based in United States, Germany and Italy. Ana Florea's co-authors include Hung Fu Tseng, Lei Qian, Lina S. Sy, Bradley K. Ackerson, Katia Bruxvoort, Yi Luo, Carla Talarico, Julia E. Tubert, Gina S. Lee and Harpreet S. Takhar and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ana Florea

38 papers receiving 1.1k citations

Hit Papers

Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and... 2022 2026 2023 2024 2022 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Florea United States 16 538 216 210 199 188 42 1.1k
Ingo Meyer Germany 17 133 0.2× 155 0.7× 24 0.1× 132 0.7× 144 0.8× 62 1.1k
Syeda Shegufta Ameer Sweden 8 49 0.1× 264 1.2× 9 0.0× 89 0.4× 198 1.1× 8 522
Benhua Zhao China 13 98 0.2× 88 0.4× 21 0.1× 109 0.5× 13 0.1× 48 453
Lifeng Lin China 13 175 0.3× 193 0.9× 12 0.1× 41 0.2× 13 0.1× 37 711
Rong Tang China 19 115 0.2× 220 1.0× 12 0.1× 185 0.9× 21 0.1× 50 1.1k
Mathew Suji Eapen Australia 22 180 0.3× 102 0.5× 15 0.1× 380 1.9× 2 0.0× 68 1.7k
Evana Akhtar Bangladesh 12 63 0.1× 194 0.9× 5 0.0× 58 0.3× 94 0.5× 26 506
Kymberly M. Gowdy United States 23 79 0.1× 297 1.4× 3 0.0× 379 1.9× 18 0.1× 78 1.4k
Jiajun Luo United States 17 38 0.1× 190 0.9× 9 0.0× 110 0.6× 143 0.8× 69 808
Lili Chen China 17 49 0.1× 92 0.4× 13 0.1× 131 0.7× 15 0.1× 79 759

Countries citing papers authored by Ana Florea

Since Specialization
Citations

This map shows the geographic impact of Ana Florea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Florea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Florea more than expected).

Fields of papers citing papers by Ana Florea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Florea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Florea. The network helps show where Ana Florea may publish in the future.

Co-authorship network of co-authors of Ana Florea

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Florea. A scholar is included among the top collaborators of Ana Florea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Florea. Ana Florea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rayens, Emily, Lina S. Sy, Lei Qian, et al.. (2025). Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series study. Annals of the Rheumatic Diseases. 84(6). 960–969. 1 indexed citations
2.
Ku, Jennifer H, Afshan Nanji, Julia E. Tubert, et al.. (2024). Risk of Corneal Graft Rejection and Vaccination: A Matched Case-Control Study From a United States Integrated Health Care System. American Journal of Ophthalmology. 263. 133–140.
3.
Tartof, Sara Y., Mark A. Schmidt, Richard Contreras, et al.. (2024). Burden of Medically Attended Diarrhea and OutpatientClostridioides difficileInfection Among Persons in 2 Large Integrated Healthcare Settings, 2016–2021. Open Forum Infectious Diseases. 11(1). ofad680–ofad680. 1 indexed citations
4.
Tseng, Hung Fu, Bradley K. Ackerson, Katia Bruxvoort, et al.. (2023). Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Nature Communications. 14(1). 189–189. 47 indexed citations
5.
Florea, Ana, Joan A. Casey, Keeve E. Nachman, et al.. (2023). Impact of California’s Senate Bill 27 on Antimicrobial-Resistant Escherichia coli Urinary Tract Infection in Humans: Protocol for a Study of Methods and Baseline Data. JMIR Research Protocols. 12. e45109–e45109. 1 indexed citations
6.
Ku, Jennifer H, Lina S. Sy, Lei Qian, et al.. (2023). Effectiveness of a fourth dose of mRNA-1273 against COVID-19 among older adults in the United States: Interim results from an observational cohort study. Vaccine. 41(29). 4212–4219. 4 indexed citations
7.
Florea, Ana, Lina S. Sy, Lei Qian, et al.. (2023). 1156. Real-World Effectiveness of Recombinant Zoster Vaccine in Chinese Adults Aged ≥50 Years in the US. Open Forum Infectious Diseases. 10(Supplement_2).
8.
Ku, Jennifer H, Lina S. Sy, Lei Qian, et al.. (2023). Vaccine effectiveness of the mRNA-1273 3-dose primary series against COVID-19 in an immunocompromised population: A prospective observational cohort study. Vaccine. 41(24). 3636–3646. 9 indexed citations
9.
Flannery, Brendan, H. Keipp Talbot, Carlos G. Grijalva, et al.. (2022). Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season. Clinical Infectious Diseases. 76(8). 1358–1363. 32 indexed citations
10.
Kim, Sara, Jessie R. Chung, H. Keipp Talbot, et al.. (2022). Effectiveness of two and three mRNA COVID‐19 vaccine doses against Omicron‐ and Delta‐Related outpatient illness among adults, October 2021–February 2022. Influenza and Other Respiratory Viruses. 16(6). 975–985. 11 indexed citations
11.
Tseng, Hung Fu, Bradley K. Ackerson, Yi Luo, et al.. (2022). Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants. Nature Medicine. 28(5). 1063–1071. 315 indexed citations breakdown →
12.
Florea, Ana, Lina S. Sy, Yi Luo, et al.. (2022). Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study. PLoS ONE. 17(4). e0267824–e0267824. 17 indexed citations
13.
Bruxvoort, Katia, Bradley K. Ackerson, Lina S. Sy, et al.. (2021). Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults. The Journal of Infectious Diseases. 225(11). 1915–1922. 30 indexed citations
14.
Bruxvoort, Katia, Lina S. Sy, Lei Qian, et al.. (2021). Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study. The Lancet Regional Health - Americas. 6. 100134–100134. 64 indexed citations
15.
Kohler, Lindsay N., Janet A. Foote, Ana Florea, et al.. (2018). Selenium and Type 2 Diabetes: Systematic Review. Nutrients. 10(12). 1924–1924. 73 indexed citations
16.
Kohler, Lindsay N., Ana Florea, Sherry Chow, et al.. (2018). Higher Plasma Selenium Concentrations Are Associated with Increased Odds of Prevalent Type 2 Diabetes. Journal of Nutrition. 148(8). 1333–1340. 50 indexed citations
17.
Florea, Ana, et al.. (2015). Reproduction indices in the Botosani Karakul females and their evolution in the reproduction period.. 63. 44–51.
18.
Dopp, Elke, L. M. Hartmann, U. von Recklinghausen, et al.. (2007). The cyto- and genotoxicity of organotin compounds is dependent on the cellular uptake capability. Toxicology. 232(3). 226–234. 21 indexed citations
19.
Dopp, Elke, L. M. Hartmann, U. von Recklinghausen, et al.. (2005). Forced Uptake of Trivalent and Pentavalent Methylated and Inorganic Arsenic and Its Cyto-/genotoxicity in Fibroblasts and Hepatoma Cells. Toxicological Sciences. 87(1). 46–56. 72 indexed citations
20.
Dopp, Elke, L. M. Hartmann, Ana Florea, et al.. (2004). Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. Toxicology and Applied Pharmacology. 201(2). 156–165. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026